Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.3531 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.3762 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.3936 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.4388 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.5038 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.5239 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.5367 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.5915 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6272 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6362 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6378 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6547 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6554 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6569 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6608 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6634 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.6733 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7010 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7074 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7096 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7103 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7203 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7238 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7309 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7585 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7651 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7865 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7916 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.7918 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8006 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8092 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8147 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8218 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8266 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8309 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8563 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8690 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8809 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8870 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8919 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8937 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.8985 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9028 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9061 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9287 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9289 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9357 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9542 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9571 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9691 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9793 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9848 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 0.9999 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0001 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0100 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0108 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0118 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0138 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0158 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0220 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0433 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0546 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.0820 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1342 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1353 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1435 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1529 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1550 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1717 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1722 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1870 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1905 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1947 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.1967 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2173 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2360 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2497 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2501 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2514 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.2929 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3034 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3078 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3110 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3152 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3197 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3239 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3436 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.3448 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.4029 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.4036 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.4577 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.4739 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.6214 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.6323 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.6337 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.6533 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.6707 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.7584 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.7648 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.7670 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.7717 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 1.9469 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 2.0159 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 2.2018 | Peak area | Normal |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 2.7025 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | N-carbamoylaspartate | 3.3322 | Peak area | Diabetic Neuropathy |